Affordable Access

Publisher Website

Management of the first recurrence of T1G3 bladder cancer: Does intravesical chemotherapy deserve a chance?

Authors
Journal
Urologic Oncology Seminars and Original Investigations
1078-1439
Publisher
Elsevier
Publication Date
Volume
27
Issue
3
Identifiers
DOI: 10.1016/j.urolonc.2008.10.027
Keywords
  • Non-Muscle-Invasive Bladder Cancer
  • Recurrence
  • Pt1
  • Grade 3
  • Chemotherapy
  • Intravesical
Disciplines
  • Medicine

Abstract

Abstract Objective Is there a role for intravesical chemotherapy in a patient who has a first recurrence of a T1G3 bladder cancer? Materials and Methods American and European guidelines are checked for their advise, and recent literature on this topic is reviewed to critically test the advice and look for potential alternative strategies in this particular case. Results Guidelines indicate that a patient with a pT1G3 tumor should initially receive BCG intravescial therapy, although cystectomy can be considered. In case of a recurrence, cystectomy is the treatment of choice. Although several new drugs and strategies are under development and in clinical research, there is only experience to some degree in BCG failing patients with thermochemotherapy, with promising results. Conclusions In a patient with a recurrence of T1G3 bladder cancer after BCG therapy, progression and subsequent cancer death is the threat. Guideline standard is radical surgery. Alternative possibilities are still limited.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

The management of T1G3 bladder cancer.

on Urologia internationalis 2002

Optimal management of the T1G3 bladder cancer.

on The Urologic clinics of North... May 2005

The optimal management of T1G3 bladder cancer.

on BJU international November 2008

T1 G3 bladder cancer.

on BJU international August 2008
More articles like this..